JMIR Retracts 2020 Diabetes AI Diagnostic Paper
According to a retraction notice on the JMIR Medical Informatics website, the JMIR Publications Editorial Office is retracting the 2020 article "Artificial Intelligence 6Based Neural Network for the Diagnosis of Diabetes: Model Development" by Yue Liu. The notice cites "identified concerns regarding potential manipulation of the submission process and the integrity of the peer review process," and says those concerns were found during an investigation of a series of related articles. The notice states that the corresponding author, Yue Liu, was contacted but did not respond to attempts at communication. For practitioners: teams that have cited or built on the 2020 paper should review those dependencies and confirm alternative, validated sources.
What happened
According to the retraction notice posted on the JMIR Medical Informatics website, JMIR Publications Editorial Office is retracting the article "Artificial Intelligence 6Based Neural Network for the Diagnosis of Diabetes: Model Development" by Yue Liu, originally published May 27, 2020 in JMIR Med Inform. The notice cites "identified concerns regarding potential manipulation of the submission process and the integrity of the peer review process," and says the concerns were identified during an investigation of a series of related articles. The notice further states that the corresponding author, Yue Liu, was contacted and offered an opportunity to comment but did not respond to attempts at communication.
Technical details
The retraction notice itself does not present technical audit details of the original model, data, or code. The published statement focuses on procedural concerns affecting the submission and peer review records rather than on a documented error in model performance or dataset provenance.
Editorial analysis
Investigations that flag potential manipulation of submission or peer review processes commonly affect multiple papers within a cluster, creating uncertainty about the reliability of the affected literature. For researchers and ML engineers working from medical-AI publications, this pattern increases the value of independent reproduction, access to code and datasets, and conservatively weighting single-study results when informing models or clinical decisions.
For practitioners
Teams that cited or operationalized results from the retracted paper should identify dependent analyses and, where feasible, re-run experiments or substitute validated alternatives. Library managers, systematic reviewers, and regulatory reviewers tracking medical-AI evidence should log the retraction and update citation databases and evidence tables accordingly.
What to watch
Observers should watch for follow-up detail from the journal about the scope of the investigation, any additional retractions in the cluster, and whether independent audits of the underlying code or data surface reproducibility issues.
Scoring Rationale
A retraction in medical-AI literature reduces confidence in affected results and matters to practitioners who cited or used the work, but it is a single-paper integrity event rather than a systemic industry shift.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
